0001209191-18-039409.txt : 20180625 0001209191-18-039409.hdr.sgml : 20180625 20180625164441 ACCESSION NUMBER: 0001209191-18-039409 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180622 FILED AS OF DATE: 20180625 DATE AS OF CHANGE: 20180625 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Varadan Anand CENTRAL INDEX KEY: 0001650456 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36167 FILM NUMBER: 18917460 MAIL ADDRESS: STREET 1: C/O CHIASMA, INC. STREET 2: 60 WELLS AVENUE CITY: NEWTON STATE: MA ZIP: 02459 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Karyopharm Therapeutics Inc. CENTRAL INDEX KEY: 0001503802 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 263931704 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 85 WELLS AVENUE STREET 2: SECOND FLOOR CITY: NEWTON STATE: MA ZIP: 02459 BUSINESS PHONE: 617-658-0600 MAIL ADDRESS: STREET 1: 85 WELLS AVENUE STREET 2: SECOND FLOOR CITY: NEWTON STATE: MA ZIP: 02459 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-06-22 0 0001503802 Karyopharm Therapeutics Inc. KPTI 0001650456 Varadan Anand C/O KARYOPHARM THERAPEUTICS INC. 85 WELLS AVE MA 02459 0 1 0 0 EVP, Chief Commercial Officer Nonstatutory Stock Option (right to buy) 18.68 2018-06-22 4 A 0 150000 0.00 A 2028-06-21 Common Stock 150000 150000 D This option was granted on June 22, 2018. The shares underlying this option vest as to 25% of the shares on June 22, 2019, with the remaining 75% vesting in 36 equal monthly installments. /s/ Christopher B. Primiano, Attorney-in-Fact for Anand Varadan 2018-06-25